(Q43439334)

23 November 2017

title

Immunomodulatory and therapeutic properties of FK-565 in mice (English)

1 reference

23 November 2017

J E Talmadge

1

1 reference

23 November 2017

B Lenz

2

1 reference

23 November 2017

M Schneider

3

1 reference

23 November 2017

H Phillips

4

1 reference

23 November 2017

C Long

5

1 reference

23 November 2017

publication date

1 January 1989

1 reference

Cancer Immunology, Immunotherapy

23 November 2017

published in

1 reference

23 November 2017

volume

28

1 reference

23 November 2017

issue

2

1 reference

23 November 2017

page(s)

93-100

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00199108

23 November 2017

exact match

0 references

cites work

Mitogenic potentials of bestatin, amastatin, arphamenines A and B, FK-156 and FK-565 on spleen lymphocytes.

1 reference

12 December 2020

The selection and characterization of an invasive variant of the B16 melanoma

1 reference

12 December 2020

Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s)

1 reference

12 December 2020

Synthesis and adjuvant activity of FK-156 analogues: acyl derivatives of N-[N2-(L-alanyl-gamma-D-glutamyl)-2(L),2'(D)-diamino-1-pimeloyl ]glycine

1 reference

12 December 2020

A transplantable mast-cell neoplasm in the mouse

1 reference

12 December 2020

Studies on a new immunoactive peptide, FK-156. I. Taxonomy of the producing strains.

1 reference

12 December 2020

Effect of indomethacin on increased resistance to bacterial infection and on febrile responses induced by muramyl dipeptide

1 reference

12 December 2020

Activation by a new synthetic acyltripeptide and its analogs entrapped in liposomes of rat alveolar macrophages to the tumor cytotoxic state

1 reference

12 December 2020

Central pyrogenic activity of muramyl dipeptide

1 reference

12 December 2020

Immunomodulatory effects in mice of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose

1 reference

12 December 2020

Immunomodulatory and therapeutic properties of bestatin in mice

1 reference

12 December 2020

1 reference

12 December 2020

Production of lymphocyte activating factor in the absence of endogenous pyrogen by rabbit or human leukocytes stimulated by a muramyl dipeptide derivative

1 reference

12 December 2020

Immunoactive peptides, FK-156 and FK-565. III. Enhancement of host defense mechanisms against infection

1 reference

12 December 2020

Muramyl peptides: Immunomodulators, sleep factors, and vitamins

1 reference

12 December 2020

Production of differentiation-stimulating factor for murine leukemic myeloblast line by monocytic cells stimulated by a nonpyrogenic muramyl dipeptide derivative.

1 reference

12 December 2020

The preclinical screening laboratory: evaluation of immunomodulatory and therapeutic properties of biological response modifiers

1 reference

12 December 2020

Activation of tumoricidal properties in macrophages and inhibition of experimentally-induced murine metastases by a new synthetic acyltripeptide, FK-565.

1 reference

12 December 2020

Immune responses in vitro. I. Culture conditions for antibody synthesis

1 reference

12 December 2020

Metastatic heterogeneity of cells from an ultraviolet light-induced murine fibrosarcoma of recent origin

1 reference

12 December 2020

Modulation of myelopoiesis in vivo by synthetic adjuvant-active muramyl peptides: induction of colony-stimulating activity and stimulation of stem cell proliferation

1 reference

12 December 2020

Macrophage involvement in the antitumor activity of a synthetic acyltripeptide (FK-565) against experimental lung carcinoma metastases

1 reference

12 December 2020

Studies on a new immunoactive peptide, FK-156. III. Structure elucidation

1 reference

12 December 2020

In Vivo Immune Responses of Mice During Carcinogenesis by Ultraviolet Irradiation 2

1 reference

12 December 2020

Latency, histology, and antigenicity of tumors induced by ultraviolet light in three inbred mouse strains

1 reference

12 December 2020

Immunoactive peptides, FK-156 and FK-565. II. Restoration of host resistance to microbial infection in immunosuppressed mice.

1 reference

12 December 2020

The effect of experimental conditions on the assessment of T cell immunomodulation by biological response modifiers (thymosin fraction five)

1 reference

12 December 2020

Immunoactive peptides, FK 156 and FK 565. IV. Activation of mouse macrophages

1 reference

12 December 2020

Studies on structure-activity relationships of FK-156, an immunostimulating peptide, and related compounds. II. Synthesis of N2-(gamma-D-glutamyl)-2(L), 2'(D)-diaminopimelic acid as the minimal essential structure of FK-156

1 reference

12 December 2020

Analysis of human blood monocyte activation at the level of gene expression. Expression of alpha interferon genes during activation of human monocytes by poly IC/LC and muramyl dipeptide

1 reference

12 December 2020

Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitors

1 reference

12 December 2020

ANTIGENIC PROPERTIES OF LYMPHOMAS INDUCED BY THE MOLONEY AGENT

1 reference

12 December 2020

Antitumor effects of novel immunoactive peptides, FK-156 and its synthetic derivatives

1 reference

12 December 2020

Studies on a new immunoactive peptide, FK-156. II. Fermentation, extraction and chemical and biological characterization

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00199108

1 reference

Dimensions Publication ID

23 November 2017

1023233360

0 references

1 reference